SlideShare a Scribd company logo
DR.MAMMEN P CHERIAN
MBBS, PGDOR
MEDICAL OFFICER IN
CHARGE, PHC NIRANAM
MOTC THIRUVALLA TU
RNTCP
Training for LSGD
MEMBERS
CHATHENKERY
24/04/2015
TB Infection
• Chances of getting infected
depends on:
1. The duration of exposure
2. The frequency of exposure
3. The immune status of an
individual
Infection
• Entry and establishment of organism in human body
• Takes about 6-8 weeks.
• Indicated by +ve tuberculin skin test.
1. Primary infection – infection occurring for the first time in a susceptible
• Individual exposed to M.tb.
• Primary complex
• Secondary bacillary multiplication that occurs at regional LN
• 2.Post primary TB – after a latent period of many months or even years after
primary infection.
• Risk of spread of infection:
• To 10-15 persons/year for 2-3 years
• Risk factors for developing disease:
• Strongest risk factor- HIV Co-infection, DM, SMOKING, ALCOHOL ABUSE
India is the highest TB burden country accounting for more than one-
fifth of the global incidence
Indonesia
6%
Nigeria
5%
Other countries
20%
Other 13 HBCs
16% China
14%
South Africa
5%
Bangladesh
4%
Ethiopia
3%
Pakistan
3%
Phillipines
3%
India
21%
Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing
Global annual incidence = 9.4 million
India annual incidence = 1.98 million
India is 17th among 22
High Burden
Countries (in terms of
TB incidence rate)
WHO estimates for TB in India (2013)
Incidence of TB
disease
2.2 million per
annum
(176 per 100,000
pop. per year)
Prevalence of TB
disease
2.8 million (230 per 100,000
pop. per year)
Mortality due to
TB
270,000 per
annum
(>900/day)
(22 per 100,000
pop. per year)
Problem of TB in India
• Incidence: >1.98 million new TB cases annually
– 0.8 million new infectious cases
– 75 NSP cases / 100,000 population / year
– Incidence more in north and less in south
– Incidence more in urban areas
– TB is more common among males
• Prevalence:
– WHO estimate (2007) – 3.3 million TB cases
• Deaths: about 2,76,000 deaths due to TB each year
– One of the leading infectious cause of death
– Nearly 1000 deaths due to TB per day; about 2 deaths every 3 minutes
Problem of TB in India..
• Infection: 40% (~400m) infected with tuberculosis bacteria
– Only 10% of them will develop TB disease in lifetime
– Co-infection with HIV increases risk of TB disease by 6 to 8 times
– Several other factors also increase this risk, e.g. diabetes, smoking, poor
nutrition, etc
• HIV :
1. 2.27 million people living with HIV; nearly 1 million co-infected with HIV and TB
2. About 5% of TB patients estimated to be HIV positive
3. HIV in TB varies greatly between districts and states (<1% to 14%)
4. More in south (except Kerala), north-east and some scattered districts
• Estimated Multi-drug resistant TB
1-3% in new cases
12-17% in re-treatment cases
• DM, SMOKING
Estimated* Incidence of TB in India
(No. of NSP Cases per 100,000 population, per year)
National 75
North Zone 95
East Zone 65**
West Zone 80
South Zone 50**
North
West East
South
* Estimated from ARTI survey
** For programme monitoring
purpose estimated cases in East &
South zones have been kept at the
national level of 75
ARTI survey by NTI 2001-2003
Annual Risk of Tuberculosis Infection(ARTI)
 Proportion of population that gets newly
infected ( or re-infected ) with tubercle
bacilli during the course of one year
 ARTI for the country is 1.5%.
For Kerala it is 1.0%
 203 cases per lakh population is
infected each year.
 135 cases/L/Year-Kerala
Type of case Occurrence /
lakh / year
NSP (Definitive) 75 cases
NSN (Probable) 75 cases
Previously
treated
38 cases
EP 15 cases
Total 203 cases
Type of case Occurrence /
lakh / year
NSP (Definitive) 50 cases
NSN (Probable) 50 cases
Previously
treated
25 cases
EP 10 cases
Total 135 cases
O
U
R
B
L
O
C
K
0
1
2
3
4
5
6
7
NSP 1Q2014
NSP 2Q2014
NSP 3Q2014
NSP 4Q2014
NEW SMEAR POSITIVE CASES
0
1
2
3
4
5
6
1
3
4
1 1
3
2
1 1 1 1 1 1 1 1 1
3
1
5
22
3
1 1 1
4
1 1
2 2
3
1
3
1 1
5
4
1 1 1
3
1
2 2
1
2
4
3
1
2 2
1
2
1
2
5
6
1 1
5
2
1 1
3
1
4
2
1 1 1
1Q2014 2Q2014 3Q2014 4Q2014
NEW SMEAR POSITIVE CASES
0
0.5
1
1.5
2
2.5
3
3.5
NSN 1Q2014
NSN 2Q2014
NSN 3Q2014
NSN 4Q2014
NEW SMEAR NEGATIVE CASES
0
0.5
1
1.5
2
2.5
3
3.5
4
1 1 1
2 2
1 1 1 1
2 2
11 1 1 1 1 11
3
2
1
2
3
1 1
4
22
1 1 1 1 1 1 1
1Q2014 2Q2014 3Q2014 4Q2014
NEW SMEAR NEGATIVE CASES
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
NEP 1Q2014
NEP 2Q2014
NEP 3Q2014
NEP 4Q2014
NEW EXTRA PULMONARY CASES
0
1
2
3
4
5
6
7
1 1
2
5
1 1 1 1 1 1
4
2
3
1
2
4
1 1 1
2
1
2
1 1 1 1 1
3
1 1
2
7
1
2
1 1 1 1 1 1
2 2
3
2
1 1
3
2
1 1 1 1 1
1Q2014 2Q2014 3Q2014 4Q2014
NEW EXTRA PULMONARY CASES
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
1 1 1 1 11 1 1 1 1
1Q2014 2Q2014 3Q2014 4Q2014
PAEDIATRICS TB
THANK YOU

More Related Content

What's hot

Aids
AidsAids
Aids
silpa k
 
Hiv disease in INDIA epidemiology
Hiv disease in INDIA epidemiologyHiv disease in INDIA epidemiology
Hiv disease in INDIA epidemiology
ABHISHEK
 
Hiv aids epidemiology & trends
Hiv aids epidemiology & trendsHiv aids epidemiology & trends
Hiv aids epidemiology & trendsS A Tabish
 
HIV/HPV
HIV/HPVHIV/HPV
HIV/HPV
thuphan95
 
Epidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hivEpidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hiv
Abhi Manu
 
HIV AIDS
HIV AIDS HIV AIDS
HIV AIDS
Chirantan MD
 
Outline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention PlanOutline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention Plan
Office of HIV Planning
 
Emerging and reemerging infectious diseases
Emerging and reemerging infectious diseasesEmerging and reemerging infectious diseases
Emerging and reemerging infectious diseases
arijitkundu88
 
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
Ravi Spikey
 
Emerging and re emerging diseases
Emerging and re emerging diseasesEmerging and re emerging diseases
Emerging and re emerging diseases
SASMITANAYAK28
 
Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015
Mehakinder Singh
 
HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis
prakashtu
 
Strategies for HIV Epidemic Control
Strategies for HIV Epidemic ControlStrategies for HIV Epidemic Control
Strategies for HIV Epidemic Control
UC San Diego AntiViral Research Center
 
Hiv aids general consideration bangladesh and international prospective new
Hiv aids general consideration  bangladesh and international prospective newHiv aids general consideration  bangladesh and international prospective new
Hiv aids general consideration bangladesh and international prospective new
Home
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
gaurav narula
 
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSRalph Bawalan
 
Basics of hiv aids management
Basics of hiv aids managementBasics of hiv aids management
Basics of hiv aids management
Dr Ketan Ranpariya
 
Hiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatmentHiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatment
Ashok Chandana
 

What's hot (20)

Aids
AidsAids
Aids
 
Hiv disease in INDIA epidemiology
Hiv disease in INDIA epidemiologyHiv disease in INDIA epidemiology
Hiv disease in INDIA epidemiology
 
Hiv aids in india
Hiv  aids in indiaHiv  aids in india
Hiv aids in india
 
Hiv aids epidemiology & trends
Hiv aids epidemiology & trendsHiv aids epidemiology & trends
Hiv aids epidemiology & trends
 
AIDS/HIV/drugs
AIDS/HIV/drugs AIDS/HIV/drugs
AIDS/HIV/drugs
 
HIV/HPV
HIV/HPVHIV/HPV
HIV/HPV
 
Epidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hivEpidemiology, prevention &amp; control of hiv
Epidemiology, prevention &amp; control of hiv
 
HIV AIDS
HIV AIDS HIV AIDS
HIV AIDS
 
Outline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention PlanOutline of the Philadelphia Prevention Plan
Outline of the Philadelphia Prevention Plan
 
Emerging and reemerging infectious diseases
Emerging and reemerging infectious diseasesEmerging and reemerging infectious diseases
Emerging and reemerging infectious diseases
 
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
Major Health Issues in India: HIV/AIDS & CANCER IN INDIA...
 
Emerging and re emerging diseases
Emerging and re emerging diseasesEmerging and re emerging diseases
Emerging and re emerging diseases
 
Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015Hiv recent guidelines naco 2015
Hiv recent guidelines naco 2015
 
HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis HIV epidemiology and pathogenesis
HIV epidemiology and pathogenesis
 
Strategies for HIV Epidemic Control
Strategies for HIV Epidemic ControlStrategies for HIV Epidemic Control
Strategies for HIV Epidemic Control
 
Hiv aids general consideration bangladesh and international prospective new
Hiv aids general consideration  bangladesh and international prospective newHiv aids general consideration  bangladesh and international prospective new
Hiv aids general consideration bangladesh and international prospective new
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
 
Communicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDSCommunicable Diseases: HIV and AIDS
Communicable Diseases: HIV and AIDS
 
Basics of hiv aids management
Basics of hiv aids managementBasics of hiv aids management
Basics of hiv aids management
 
Hiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatmentHiv epi, diagnosis and treatment
Hiv epi, diagnosis and treatment
 

Similar to Tuberculosis sensitation for lsgd by Dr.Mammen P Cherian

street theatre.ppt
street theatre.pptstreet theatre.ppt
street theatre.ppt
joshva raja john
 
Hiv in tuberculosis
Hiv in tuberculosis Hiv in tuberculosis
Hiv in tuberculosis
HahLa2
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
Rama shankar
 
Raviglionemilano14 3-2013-130325105725-phpapp01
Raviglionemilano14 3-2013-130325105725-phpapp01Raviglionemilano14 3-2013-130325105725-phpapp01
Raviglionemilano14 3-2013-130325105725-phpapp01supermary2
 
58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish
homeworkping3
 
32331.ppt
32331.ppt32331.ppt
32331.ppt
Rajveer71
 
HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014
drdduttaM
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
AB Rajar
 
Peadiatrics HIV BY MWEBAZA VICTOR.pptx
Peadiatrics HIV BY  MWEBAZA VICTOR.pptxPeadiatrics HIV BY  MWEBAZA VICTOR.pptx
Peadiatrics HIV BY MWEBAZA VICTOR.pptx
Dr. MWEBAZA VICTOR
 
HIV-AIDS
HIV-AIDSHIV-AIDS
Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...
UC San Diego AntiViral Research Center
 
RNTCP
RNTCPRNTCP
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
drjagannath
 
HIV AIDS for paramedical workers
HIV AIDS for paramedical workersHIV AIDS for paramedical workers
HIV AIDS for paramedical workers
Daisy Dharmaraj
 
newrntcp-160127070415.pdf
newrntcp-160127070415.pdfnewrntcp-160127070415.pdf
newrntcp-160127070415.pdf
Manasranjanbehera43
 
HIV-AIDS an alarming growing global concern.ppt
HIV-AIDS  an alarming growing global concern.pptHIV-AIDS  an alarming growing global concern.ppt
HIV-AIDS an alarming growing global concern.ppt
joshva raja john
 
HIV-AIDS an alarming growing global concern.ppt
HIV-AIDS  an alarming growing global concern.pptHIV-AIDS  an alarming growing global concern.ppt
HIV-AIDS an alarming growing global concern.ppt
joshva raja john
 
Hivaids sachin bhatt
Hivaids sachin bhattHivaids sachin bhatt
Hivaids sachin bhatt
Sachin Bhatt
 

Similar to Tuberculosis sensitation for lsgd by Dr.Mammen P Cherian (20)

street theatre.ppt
street theatre.pptstreet theatre.ppt
street theatre.ppt
 
Tb burden of disease
Tb burden of diseaseTb burden of disease
Tb burden of disease
 
Hiv in tuberculosis
Hiv in tuberculosis Hiv in tuberculosis
Hiv in tuberculosis
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
 
Raviglionemilano14 3-2013-130325105725-phpapp01
Raviglionemilano14 3-2013-130325105725-phpapp01Raviglionemilano14 3-2013-130325105725-phpapp01
Raviglionemilano14 3-2013-130325105725-phpapp01
 
58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish58864328 tb-hiv-research-proposal-harish
58864328 tb-hiv-research-proposal-harish
 
32331.ppt
32331.ppt32331.ppt
32331.ppt
 
HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014HIV & AIDS 05.12.2014
HIV & AIDS 05.12.2014
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
 
Peadiatrics HIV BY MWEBAZA VICTOR.pptx
Peadiatrics HIV BY  MWEBAZA VICTOR.pptxPeadiatrics HIV BY  MWEBAZA VICTOR.pptx
Peadiatrics HIV BY MWEBAZA VICTOR.pptx
 
Final pptct mod 1
Final pptct mod 1Final pptct mod 1
Final pptct mod 1
 
HIV-AIDS
HIV-AIDSHIV-AIDS
HIV-AIDS
 
Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...
 
RNTCP
RNTCPRNTCP
RNTCP
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
 
HIV AIDS for paramedical workers
HIV AIDS for paramedical workersHIV AIDS for paramedical workers
HIV AIDS for paramedical workers
 
newrntcp-160127070415.pdf
newrntcp-160127070415.pdfnewrntcp-160127070415.pdf
newrntcp-160127070415.pdf
 
HIV-AIDS an alarming growing global concern.ppt
HIV-AIDS  an alarming growing global concern.pptHIV-AIDS  an alarming growing global concern.ppt
HIV-AIDS an alarming growing global concern.ppt
 
HIV-AIDS an alarming growing global concern.ppt
HIV-AIDS  an alarming growing global concern.pptHIV-AIDS  an alarming growing global concern.ppt
HIV-AIDS an alarming growing global concern.ppt
 
Hivaids sachin bhatt
Hivaids sachin bhattHivaids sachin bhatt
Hivaids sachin bhatt
 

Recently uploaded

Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
Mangaiarkkarasi
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
mahalsuraj389
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
Azreen Aj
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
Dharma Homoeopathy
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
shanicedivinagracia2
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
BeshedaWedajo
 

Recently uploaded (20)

Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 

Tuberculosis sensitation for lsgd by Dr.Mammen P Cherian

  • 1. DR.MAMMEN P CHERIAN MBBS, PGDOR MEDICAL OFFICER IN CHARGE, PHC NIRANAM MOTC THIRUVALLA TU RNTCP Training for LSGD MEMBERS CHATHENKERY 24/04/2015
  • 2. TB Infection • Chances of getting infected depends on: 1. The duration of exposure 2. The frequency of exposure 3. The immune status of an individual
  • 3. Infection • Entry and establishment of organism in human body • Takes about 6-8 weeks. • Indicated by +ve tuberculin skin test. 1. Primary infection – infection occurring for the first time in a susceptible • Individual exposed to M.tb. • Primary complex • Secondary bacillary multiplication that occurs at regional LN • 2.Post primary TB – after a latent period of many months or even years after primary infection. • Risk of spread of infection: • To 10-15 persons/year for 2-3 years • Risk factors for developing disease: • Strongest risk factor- HIV Co-infection, DM, SMOKING, ALCOHOL ABUSE
  • 4. India is the highest TB burden country accounting for more than one- fifth of the global incidence Indonesia 6% Nigeria 5% Other countries 20% Other 13 HBCs 16% China 14% South Africa 5% Bangladesh 4% Ethiopia 3% Pakistan 3% Phillipines 3% India 21% Source: WHO Geneva; WHO Report 2009: Global Tuberculosis Control; Surveillance, Planning and Financing Global annual incidence = 9.4 million India annual incidence = 1.98 million India is 17th among 22 High Burden Countries (in terms of TB incidence rate)
  • 5. WHO estimates for TB in India (2013) Incidence of TB disease 2.2 million per annum (176 per 100,000 pop. per year) Prevalence of TB disease 2.8 million (230 per 100,000 pop. per year) Mortality due to TB 270,000 per annum (>900/day) (22 per 100,000 pop. per year)
  • 6. Problem of TB in India • Incidence: >1.98 million new TB cases annually – 0.8 million new infectious cases – 75 NSP cases / 100,000 population / year – Incidence more in north and less in south – Incidence more in urban areas – TB is more common among males • Prevalence: – WHO estimate (2007) – 3.3 million TB cases • Deaths: about 2,76,000 deaths due to TB each year – One of the leading infectious cause of death – Nearly 1000 deaths due to TB per day; about 2 deaths every 3 minutes
  • 7. Problem of TB in India.. • Infection: 40% (~400m) infected with tuberculosis bacteria – Only 10% of them will develop TB disease in lifetime – Co-infection with HIV increases risk of TB disease by 6 to 8 times – Several other factors also increase this risk, e.g. diabetes, smoking, poor nutrition, etc • HIV : 1. 2.27 million people living with HIV; nearly 1 million co-infected with HIV and TB 2. About 5% of TB patients estimated to be HIV positive 3. HIV in TB varies greatly between districts and states (<1% to 14%) 4. More in south (except Kerala), north-east and some scattered districts • Estimated Multi-drug resistant TB 1-3% in new cases 12-17% in re-treatment cases • DM, SMOKING
  • 8. Estimated* Incidence of TB in India (No. of NSP Cases per 100,000 population, per year) National 75 North Zone 95 East Zone 65** West Zone 80 South Zone 50** North West East South * Estimated from ARTI survey ** For programme monitoring purpose estimated cases in East & South zones have been kept at the national level of 75 ARTI survey by NTI 2001-2003
  • 9. Annual Risk of Tuberculosis Infection(ARTI)  Proportion of population that gets newly infected ( or re-infected ) with tubercle bacilli during the course of one year  ARTI for the country is 1.5%. For Kerala it is 1.0%  203 cases per lakh population is infected each year.  135 cases/L/Year-Kerala Type of case Occurrence / lakh / year NSP (Definitive) 75 cases NSN (Probable) 75 cases Previously treated 38 cases EP 15 cases Total 203 cases Type of case Occurrence / lakh / year NSP (Definitive) 50 cases NSN (Probable) 50 cases Previously treated 25 cases EP 10 cases Total 135 cases
  • 11. 0 1 2 3 4 5 6 7 NSP 1Q2014 NSP 2Q2014 NSP 3Q2014 NSP 4Q2014 NEW SMEAR POSITIVE CASES
  • 12. 0 1 2 3 4 5 6 1 3 4 1 1 3 2 1 1 1 1 1 1 1 1 1 3 1 5 22 3 1 1 1 4 1 1 2 2 3 1 3 1 1 5 4 1 1 1 3 1 2 2 1 2 4 3 1 2 2 1 2 1 2 5 6 1 1 5 2 1 1 3 1 4 2 1 1 1 1Q2014 2Q2014 3Q2014 4Q2014 NEW SMEAR POSITIVE CASES
  • 13. 0 0.5 1 1.5 2 2.5 3 3.5 NSN 1Q2014 NSN 2Q2014 NSN 3Q2014 NSN 4Q2014 NEW SMEAR NEGATIVE CASES
  • 14. 0 0.5 1 1.5 2 2.5 3 3.5 4 1 1 1 2 2 1 1 1 1 2 2 11 1 1 1 1 11 3 2 1 2 3 1 1 4 22 1 1 1 1 1 1 1 1Q2014 2Q2014 3Q2014 4Q2014 NEW SMEAR NEGATIVE CASES
  • 15. 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 NEP 1Q2014 NEP 2Q2014 NEP 3Q2014 NEP 4Q2014 NEW EXTRA PULMONARY CASES
  • 16. 0 1 2 3 4 5 6 7 1 1 2 5 1 1 1 1 1 1 4 2 3 1 2 4 1 1 1 2 1 2 1 1 1 1 1 3 1 1 2 7 1 2 1 1 1 1 1 1 2 2 3 2 1 1 3 2 1 1 1 1 1 1Q2014 2Q2014 3Q2014 4Q2014 NEW EXTRA PULMONARY CASES
  • 17. 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1 1 1 1 11 1 1 1 1 1Q2014 2Q2014 3Q2014 4Q2014 PAEDIATRICS TB